Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma

par Pacenta, Holly L, Macy, Margaret E
Publié dans Drug Des Devel Ther (2018)

Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents

par Macy, Margaret E., DeRyckere, Deborah, Gore, Lia
Publié 2010

Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas

par Liu, Arthur K., Macy, Margaret E., Foreman, Nicholas K.
Publié 2009

Undifferentiated Sarcoma of the Liver: A Single Institution Experience Using a Uniform Treatment Approach

par May, Lauren T., Wang, Michael, Albano, Edythe, Garrington, Timothy, Dishop, Megan, Macy, Margaret E.
Publié 2012

Novel Therapies for Pediatric Cancers

par Macy, Margaret E., Sawczyn, Kelly K., Garrington, Timothy P., Graham, Douglas K., Gore, Lia
Publié 2008

Central nervous system involvement of rhabdomyosarcoma: A single institution experience

par Moreira, Daniel C., Macy, Margaret E., Cost, Carrye R., Greffe, Brian S., Garrington, Timothy P.
Publié dans J Pediatr Hematol Oncol (2019)

Bevacizumab in the treatment of radiation injury for children with central nervous system tumors

par Dahl, Nathan A., Liu, Arthur, Foreman, Nicholas, Widener, Melissa, Fenton, Laura, Macy, Margaret E.
Publié dans Childs Nerv Syst (2019)

Opportunities and Challenges in Drug Development for Pediatric Cancers

par Laetsch, Theodore W., DuBois, Steven G., Bender, Julia Glade, Macy, Margaret E., Moreno, Lucas
Publié dans Cancer Discov (2020)

The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation

par Lauro, Christine, Macy, Margaret E., Zeitler, Philip, Backus, Jennifer, Mettler, Pamela, Foreman, Nicholas, Liu, Arthur K.
Publié 2014

A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood

par Cohen, Kenneth J., Gibbs, Iris C., Fisher, Paul G., Hayashi, Robert J., Macy, Margaret E., Gore, Lia
Publié 2013

Clinical and molecular characteristics of congenital glioblastoma

par Macy, Margaret E., Birks, Diane K., Barton, Valerie N., Chan, Michael H., Donson, Andrew M., Kleinschmidt-DeMasters, B.K., Bemis, Lynne T., Handler, Michael H., Foreman, Nicholas K.
Publié 2012

A Multi-Center Phase Ib Study of Oxaliplatin (NSC#266046) in Combination with Fluorouracil and Leucovorin in Pediatric Patients with Advanced Solid Tumors

par Macy, Margaret E., Duncan, Tracey, Whitlock, James, Hunger, Stephen P., Boklan, Jessica, Narendren, Aru, Herzog, Cynthia, Arceci, Robert J., Bagatell, Rochelle, Trippett, Tanya, Christians, Uwe, Rolla, Katherine, Ivy, S. Percy, Gore, Lia
Publié 2012

A Phase 1 Study of the CXCR4 Antagonist Plerixafor in Combination With High-Dose Cytarabine and Etoposide in Children With Relapsed or Refractory Acute Leukemias or Myelodysplastic...

par Cooper, Todd M., Sison, Edward Allan Racela, Baker, Sharyn D., Li, Lie, Ahmed, Amina, Trippett, Tanya, Gore, Lia, Macy, Margaret E., Narendran, Aru, August, Keith, Absalon, Michael J., Boklan, Jessica, Pollard, Jessica, Magoon, Daniel, Brown, Patrick A.
Publié dans Pediatr Blood Cancer (2017)

A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas

par Macy, Margaret E., Kieran, Mark W., Chi, Susan N., Cohen, Kenneth J., MacDonald, Tobey J., Smith, Amy A., Etzl, Michael M., Kuei, Michele C., Donson, Andrew M., Gore, Lia, DiRenzo, Jennifer, Trippett, Tanya M., Ostrovnaya, Irina, Narendran, Aru, Foreman, Nicholas K., Dunkel, Ira J.
Publié dans Pediatr Blood Cancer (2017)

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

par Gore, Lia, Triche, Timothy J., Farrar, Jason E., Wai, Daniel, Legendre, Christophe, Gooden, Gerald C., Liang, Winnie S., Carpten, John, Lee, David, Alvaro, Frank, Macy, Margaret E., Arndt, Carola, Barnette, Philip, Cooper, Todd, Martin, Laura, Narendran, Aru, Pollard, Jessica, Meshinchi, Soheil, Boklan, Jessica, Arceci, Robert J., Salhia, Bodour
Publié dans Clin Epigenetics (2017)

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial

par Pinto, Navin, DuBois, Steven G., Marachelian, Araz, Diede, Scott J., Taraseviciute, Agne, Glade Bender, Julia L., Tsao-Wei, Denice, Groshen, Susan G., Reid, Joel M., Haas-Kogan, Daphne A., Reynolds, C. Patrick, Kang, Min H., Irwin, Meredith S., Macy, Margaret E., Villablanca, Judith G., Matthay, Katherine K., Park, Julie R.
Publié dans Pediatr Blood Cancer (2018)

Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

par DuBois, Steven G., Mosse, Yael P., Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., McGovern, Renee, Groshen, Susan, Bagatell, Rochelle, Maris, John M., Twist, Clare J., Goldsmith, Kelly, Granger, M. Meaghan, Weiss, Brian, Park, Julie R., Macy, Margaret E., Cohn, Susan L., Yanik, Greg, Wagner, Lars, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Tsao-Wei, Denice D., Matthay, Katherine K., Marachelian, Araz
Publié dans Clin Cancer Res (2018)